Endocrine treatment of prostate cancer: standard treatment and new perspectives.
The hormonal treatment of advanced prostate cancer is still a controversial matter although new drugs are being tested in clinical trials all over the world. The results of these trials are the subject of dispute for reasons related to the natural history and clinical evolution of prostate cancer.
Boccardo
F
F
Department of Medical Oncology 2, National Institute for Cancer Research, Genoa, Italy.
Pace
M
M
D000726:Androgen Antagonists / Q000627:therapeutic use*; D002277:Carcinoma / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004967:Estrogens / Q000627:therapeutic use*; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D015337:Multicenter Studies as Topic; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D009919:Orchiectomy; D011446:Prospective Studies; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery
D000726:Androgen Antagonists; D004967:Estrogens; D007987:Gonadotropin-Releasing Hormone